Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 28;7(5):1187.
doi: 10.4022/jafib.1187. eCollection 2015 Feb-Mar.

The Atrial Fibrillation Therapies after ER visit: Outpatient Care for Patients with Acute AF - The AFTER3 Study

Affiliations

The Atrial Fibrillation Therapies after ER visit: Outpatient Care for Patients with Acute AF - The AFTER3 Study

Paul Angaran et al. J Atr Fibrillation. .

Abstract

Background: Visits to the emergency room (ER) for atrial fibrillation/flutter (AF) are common, but follow-up care is rarely systematically organized and is often delayed.

Purpose: We conducted a pilot program to develop a systematic, protocol-based system of care for patients presenting to the ER with a primary diagnosis of AF.

Methods: Consecutive patients presenting to the ER with ECG-documented AF at an urban teaching hospital were treated according to a guideline-based care protocol, including a patient toolkit at ER discharge, and systematic referral to a rapid access AF clinic. Consenting patients received questionnaires on AF knowledge, patient satisfaction, and the AFEQT questionnaire at first visit and three-month follow-up.

Results: Of the 321 patients with AF, 244 (76%) were discharged from the ER and 166 (68%) were referred to the AF clinic for urgent follow-up. Among 166 referred, 144 (87%) were seen, within a median 10.5 days (IQR 6-16.5 days); 128 (89%) patients agreed to participate in the study and 81% received a toolkit in the ER. The mean age of patients seen in AF clinic was 63.6±13.2 years and 59% were male. Eighty-seven percent were aware of their diagnosis, stroke risk (82%), possible complications (90%), treatment options (86%) and benefits of adherence (86%). Severity of Atrial Fibrillation class was > 2 in 51% at baseline; AFEQT scores increased from baseline (56.4±25.5) to three months post-ER visit (76.4±20.0), a moderately large improvement in QOL (p<0.0001). Seventy eight percent of patients with CHA2DS2-VASc score > 1 were treated with an oral anticoagulant.

Conclusions: A systematic program to improve patient transition of care from the ER to community clinic was associated with prompt, guideline-based care, and high levels of patient disease awareness. Quality of life scores improved substantially between the index ER visit and 3 months post-visit.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. AFTER3 Patient Recruitment (March 2012 - August 2013)
Admitted – Patients admitted to hospital; Discharged from ED – Patients discharged home from the ED; Not referred – Patients not referred to the AF Clinic; Referred to AF Clinic – Referrals were faxed/copied and placed in ED binder and patient was given an appointment at ED discharged; Not seen in AF Clinic – Patients cancelled their appointment or were no shows; Seen in AF Clinic – Patients who came for their scheduled AF Clinic appointment; Not Enrolled into AFTER3 – Patient declined, limited English, met exclusion criteria; Recruited into AFTER3 – Patients who met inclusion criteria and were recruited into the AFTER3 Study
Figure 2A.
Figure 2A.. Stroke Prevention Treatment in the AF Clinic (N=128)
*N=126 (data is missing for 2 patients), † 1 started ASA, ‡ 1 started ASA AF – Atrial fibrillation; OAC – oral anticoagulant; D/C – Discharged; AFC – Atrial Fibrillation Clinic; GP – General Practitioner
Figure 2B.
Figure 2B.. Stroke Prevention Treatment in the AF Clinic with a CHA2DS2-VASc≥2 (N=72)
* CHA2DS2-VASc≥2 (N=72) – (data is missing for 2 patients), AF – Atrial fibrillation; OAC – oral anticoagulant; D/C – Discharged; AFC – Atrial Fibrillation Clinic; GP – General Practitioner

References

    1. Chugh Sumeet S, Havmoeller Rasmus, Narayanan Kumar, Singh David, Rienstra Michiel, Benjamin Emelia J, Gillum Richard F, Kim Young-Hoon, McAnulty John H, Zheng Zhi-Jie, Forouzanfar Mohammad H, Naghavi Mohsen, Mensah George A, Ezzati Majid, Murray Christopher J L. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014 Feb 25;129 (8):837–47. - PMC - PubMed
    1. Benjamin E J, Wolf P A, D'Agostino R B, Silbershatz H, Kannel W B, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998 Sep 8;98 (10):946–52. - PubMed
    1. Hart R G, Benavente O, McBride R, Pearce L A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann. Intern. Med. 1999 Oct 5;131 (7):492–501. - PubMed
    1. Go Alan S, Hylek Elaine M, Chang Yuchiao, Phillips Kathleen A, Henault Lori E, Capra Angela M, Jensvold Nancy G, Selby Joe V, Singer Daniel E. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003 Nov 26;290 (20):2685–92. - PubMed
    1. Verma Atul, Cairns John A, Mitchell L Brent, Macle Laurent, Stiell Ian G, Gladstone David, McMurtry Michael Sean, Connolly Stuart, Cox Jafna L, Dorian Paul, Ivers Noah, Leblanc Kori, Nattel Stanley, Healey Jeff S. 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol. 2014 Oct;30 (10):1114–30. - PubMed

LinkOut - more resources